Background: Dedifferentiated liposarcoma (DDLPS) is one of the most deadly types of soft tissue sarcoma. To date, there have been few studies dedicated to elucidating the molecular mechanisms behind the disease; therefore, the molecular mechanisms behind this malignancy remain largely unknown.

Materials And Methods: Microarray profiles of 46 DDLPS samples and nine normal fat controls were extracted from Gene Expression Omnibus (GEO). Quality control for these microarray profiles was performed before analysis. Hierarchical clustering and principal component analysis were used to distinguish the general differences in gene expression between DDLPS samples and the normal fat controls. Differentially expressed genes (DEGs) were identified using the Limma package in R. Next, the enriched Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were obtained using the online tool DAVID (http://david.abcc.ncifcrf.gov/). A protein-protein interaction (PPI) network was constructed using the STRING database and Cytoscape software. Furthermore, the hub genes within the PPI network were identified.

Results: All 55 microarray profiles were confirmed to be of high quality. The gene expression pattern of DDLPS samples was significantly different from that of normal fat controls. In total, 700 DEGs were identified, and 83 enriched GO terms and three KEGG pathways were obtained. Specifically, within the DEGs of DDLPS samples, several pathways were identified as being significantly enriched, including the PPAR signaling pathway, cell cycle pathway, and pyruvate metabolism pathway. Furthermore, the dysregulated PPI network of DDLPS was constructed, and 14 hub genes were identified. Characteristic of DDLPS, the genes and were universally found to be up-regulated and amplified in gene copy number.

Conclusion: This study used bioinformatics to comprehensively mine DDLPS microarray data in order to obtain a deeper understanding of the molecular mechanism of DDLPS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481278PMC
http://dx.doi.org/10.2147/OTT.S132071DOI Listing

Publication Analysis

Top Keywords

ddlps samples
16
molecular mechanisms
12
microarray profiles
12
samples normal
12
normal fat
12
fat controls
12
gene expression
12
ppi network
12
ddlps
9
dedifferentiated liposarcoma
8

Similar Publications

Oncogenic Functions of Alternatively Spliced Isoform in Retroperitoneal Liposarcoma.

Int J Mol Sci

December 2024

The James Comprehensive Cancer Center, Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.

Retroperitoneal liposarcoma (RPLPS) is one of the most common histologic subtypes of soft tissue sarcoma (STS). Complete surgical resection remains the mainstay treatment, while the high rate of locoregional recurrence constitutes the predominant cause of mortality. Well-differentiated (WDLPS) and dedifferentiated (DDLPS) liposarcoma are the most frequent subtypes of RPLPS and present amplified MDM2 gene as a hallmark.

View Article and Find Full Text PDF

Integrated lipidomics and RNA-seq reveal prognostic biomarkers in well-differentiated and dedifferentiated retroperitoneal liposarcoma.

Cancer Cell Int

December 2024

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute, Beijing, 100142, P. R. China.

Background: Retroperitoneal liposarcoma (RLPS) is a mesenchymal malignant tumor characterized by different degrees of adipocytic differentiation. Well-differentiated liposarcoma (WDLPS) and dedifferentiated liposarcoma (DDLPS) are two of the most common subtypes of RLPS, exhibiting clear differences in biological behaviors and clinical prognosis. The metabolic features and genomic characteristics remain unclear.

View Article and Find Full Text PDF

Dedifferentiated liposarcoma (DDLPS) comprises a high-grade dedifferentiated (DD) component and a juxtaposed well-differentiated (WD) component. The DD component is believed to originate from the WD component by acquiring additional genomic alterations. In this study, we performed multiregion genome, epigenome, and transcriptome analyses of three patients with DDLPS.

View Article and Find Full Text PDF
Article Synopsis
  • This phase II study (Alliance A091401) evaluates the effectiveness of nivolumab (N) alone and in combination with ipilimumab (N+I) on patients with different types of sarcomas, focusing on treatment responses and biomarkers.
  • The study involved 66 patients with various sarcoma types, and while neither N nor N+I showed positive responses in gastrointestinal stromal tumors (GIST), N+I had a better response in dedifferentiated liposarcoma (DDLPS) and undifferentiated pleomorphic sarcoma (UPS).
  • Results highlighted that traditional biomarkers did not predict immunotherapy response, but genomic instability markers correlated with better clinical outcomes, emphasizing the need for more research in
View Article and Find Full Text PDF
Article Synopsis
  • The study aims to assess the effectiveness of immunohistochemistry markers p16, MDM2, and CDK4 in diagnosing well-differentiated and de-differentiated liposarcoma, using Fluorescent in situ Hybridisation (FISH) as a reference standard.
  • Conducted at the Armed Forces Institute of Pathology in Pakistan over 18 months, the research analyzed 36 cases already tested with FISH, comparing the results of the immunohistochemistry markers.
  • Findings revealed that while CDK4 showed the highest sensitivity, MDM2 had the greatest specificity; however, FISH remains the most reliable diagnostic method, emphasizing that a combination of markers can enhance diagnostic accuracy.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!